Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2

被引:7
作者
Gross-Cohen, Miriam [1 ]
Feld, Sari [1 ]
Arvatz, Gil [1 ]
Ilan, Neta [1 ]
Vlodavsky, Israel [1 ]
机构
[1] Technion, Technion Integrated Canc Ctr, Rappaport Fac Med, Haifa, Israel
来源
FRONTIERS IN ONCOLOGY | 2021年 / 10卷
基金
以色列科学基金会;
关键词
heparanase; 2; heparan sulfate; adhesion; migration; scattering;
D O I
10.3389/fonc.2020.627463
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Unlike the intense research effort devoted to exploring the significance of heparanase in human diseases, very little attention was given to its close homolog, heparanase 2 (Hpa2). The emerging role of Hpa2 in a rare autosomal recessive congenital disease called urofacial syndrome (UFS), clearly indicates that Hpa2 is not a pseudogene but rather a gene coding for an important protein. Hpa2 lacks the heparan sulfate (HS)-degrading activity typical of heparanase, yet exhibits high affinity to HS, affinity that is 10-fold higher than that of heparanase. The consequences of this high-affinity interaction of Hpa2 with plasma membrane HSPG has not been explored yet. Here, we used highly purified Hpa2 protein to examine this aspect. We provide evidence that cells adhere to and spread on dishes coated with Hpa2. We also show that cell migration is attenuated markedly by exogenous addition of Hpa2 to primary and transformed cells, a function that agrees with the anti-cancer properties of Hpa2. Interestingly, we found that exogenous addition of Hpa2 also disrupts the morphology of cell colonies, resulting in cell scattering. This implies that under certain conditions and experimental settings, Hpa2 may exhibit pro-tumorigenic properties. We further developed a panel of anti-Hpa2 monoclonal antibodies (mAb) and show that these properties of Hpa2 are prevented by some of the newly-developed mAb, thus providing new molecular tools to better appreciate the significance of Hpa2 in health and disease.
引用
收藏
页数:12
相关论文
共 60 条
[1]   Syndecans - key regulators of cell signaling and biological functions [J].
Afratis, Nikolaos A. ;
Nikitovic, Dragana ;
Multhaupt, Hinke A. B. ;
Theocharis, Achilleas D. ;
Couchman, John R. ;
Karamanos, Nikos K. .
FEBS JOURNAL, 2017, 284 (01) :27-41
[2]   Heparanase enhances myeloma progression via CXCL10 downregulation [J].
Barash, U. ;
Zohar, Y. ;
Wildbaum, G. ;
Beider, K. ;
Nagler, A. ;
Karin, N. ;
Ilan, N. ;
Vlodavsky, I. .
LEUKEMIA, 2014, 28 (11) :2178-2187
[3]   Heparanase promotes glioma progression via enhancing CD24 expression [J].
Barash, Uri ;
Spyrou, Argyris ;
Liu, Pei ;
Vlodaysky, Euvgeni ;
Zhu, Chenchen ;
Luo, Juanjuan ;
Su, Dongsheng ;
Ilhan, Neta ;
Forsberg-Nilsson, Karin ;
Vlodaysky, Israel ;
Yang, Xiaojun .
INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (06) :1596-1608
[4]   Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling [J].
Bass, MD ;
Humphries, MJ .
BIOCHEMICAL JOURNAL, 2002, 368 :1-15
[5]   Syndecans in tumor cell adhesion and signaling [J].
Beauvais D.M. ;
Rapraeger A.C. .
Reproductive Biology and Endocrinology, 2 (1)
[6]   Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth [J].
Bhattacharya, Udayan ;
Gutter-Kapon, Lilach ;
Kan, Tal ;
Boyango, Ilanit ;
Barash, Uri ;
Yang, Shi-Ming ;
Liu, JingJing ;
Gross-Cohen, Miriam ;
Sanderson, Ralph D. ;
Shaked, Yuval ;
Ilan, Neta ;
Vlodavsky, Israel .
CANCER RESEARCH, 2020, 80 (01) :57-68
[7]   Macrophage Activation by Heparanase Is Mediated by TLR-2 and TLR-4 and Associates With Plaque Progression [J].
Blich, Miry ;
Golan, Amnon ;
Arvatz, Gil ;
Sebbag, Anat ;
Shafat, Itay ;
Sabo, Edmond ;
Cohen-Kaplan, Victoria ;
Petcherski, Sirouch ;
Avniel-Polak, Shani ;
Eitan, Amnon ;
Hammerman, Haim ;
Aronson, Doron ;
Axelman, Elena ;
Ilan, Neta ;
Nussbaum, Gabriel ;
Vlodavsky, Israel .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (02) :E56-+
[8]   Heparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis [J].
Boyango, Ilanit ;
Barash, Uri ;
Naroditsky, Inna ;
Li, Jin-Ping ;
Hammond, Edward ;
Ilan, Neta ;
Vlodavsky, Israel .
CANCER RESEARCH, 2014, 74 (16) :4504-4514
[9]   Non-Anticoagulant Heparins and Inhibition of Cancer [J].
Casu, Benito ;
Vlodavsky, Israel ;
Sanderson, Ralph D. .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2007, 36 (3-4) :195-203
[10]   Heparanase Loosens E-Cadherin-Mediated Cell-Cell Contact via Activation of Src [J].
Cohen-Kaplan, Victoria ;
Ilan, Neta ;
Vlodavsky, Israel .
FRONTIERS IN ONCOLOGY, 2020, 10